Joop Gaken

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.

MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.

Journal: Molecular oncology

Published: March 26, 2018

miR-181c-BRK1 axis plays a key role in actin cytoskeleton-dependent T cell function.

miR-181c-BRK1 axis plays a key role in actin cytoskeleton-dependent T cell function.

Journal: Journal of leukocyte biology

Published: August 15, 2017

Retroviral insertional mutagenesis implicates E3 ubiquitin ligase RNF168 in the control of cell proliferation and survival.

Retroviral insertional mutagenesis implicates E3 ubiquitin ligase RNF168 in the control of cell proliferation and survival.

Journal: Bioscience reports

Published: May 23, 2017

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.

Journal: Oncotarget

Published: March 22, 2016

Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cells.

Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cells.

Journal: Apoptosis : an international journal on programmed cell death

Published: April 02, 2015

CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.

CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.

Journal: The Lancet. Haematology

Published: January 13, 2015

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).

Journal: Leukemia

Published: December 18, 2014

Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.

Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.

Journal: Blood

Published: August 21, 2014

MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.

MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.

Journal: International journal of cancer

Published: July 16, 2014

Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.

Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.

Journal: Blood

Published: June 14, 2013

TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

Journal: British journal of haematology

Published: September 25, 2012

Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken anaemia virus derived VP3/Apoptin.

Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken anaemia virus derived VP3/Apoptin.

Journal: Cell death & disease

Published: April 13, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026